Literature DB >> 1093358

Pharmacokinetics of clofibrate and chlorophenoxy isobutyric aicd. I. Cross-over studies on human volunteers.

P T Männistö, J Tuomisto, A Jounela, O Penttilä.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1093358     DOI： 10.1111/j.1600-0773.1975.tb00802.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetics of hypolipidaemic drugs.

Authors:  R Gugler
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models.

Authors:  Scott P Davies; Courtney J Mycroft-West; Isabel Pagani; Harriet J Hill; Yen-Hsi Chen; Richard Karlsson; Ieva Bagdonaite; Scott E Guimond; Zania Stamataki; Marcelo Andrade De Lima; Jeremy E Turnbull; Zhang Yang; Elisa Vicenzi; Mark A Skidmore; Farhat L Khanim; Alan Richardson
Journal:  Front Pharmacol       Date:  2021-08-06       Impact factor: 5.988

4.  Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.

Authors:  J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

5.  Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.

Authors:  U Abshagen; S Spörl-Radun; J Marinow
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

6.  Bioavailability of p-chlorophenoxyisobutyric acid (clofibrinic acid) after repeated doses of its calcium salt to humans.

Authors:  T Taylor; L F Chasseaud; A Darragh; D A O'Kelly
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.